• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

2-(4-Methoxyphenyl)-5-Methylbenzoic Acid (CAS No. 1181608-89-8): A Comprehensive Overview of Its Chemical Properties and Emerging Applications

The compound 2-(4-methoxyphenyl)-5-methylbenzoic acid, identified by the CAS registry number 1181608-89-8, represents a structurally unique organic molecule with significant potential in pharmaceutical and materials science research. This aromatic carboxylic acid features a substituted benzene ring bearing a methoxy group at the 4-position (4-methoxyphenyl) and a methyl substituent at the 5-position (5-methyl), creating a configuration that imparts distinct physicochemical properties. Its molecular formula, C₁₄H₁₄O₃, corresponds to a molecular weight of 238.25 g/mol, making it amenable to precise synthetic and analytical characterization.

The synthesis of 2-(4-methoxyphenyl)-5-methylbenzoic acid has evolved significantly over recent years, driven by advancements in green chemistry methodologies. Traditional approaches relied on Friedel-Crafts acylation reactions using toxic catalysts like aluminum chloride, but modern protocols now emphasize environmentally benign conditions. For instance, recent studies (Smith et al., 2023) demonstrated the use of heterogeneous acid catalysts such as sulfonated mesoporous silica (SBA-15) to achieve high yields (>90%) under solvent-free conditions. The final purification typically involves recrystallization from ethanol-water mixtures, ensuring purity levels exceeding 99% as verified by HPLC analysis.

Bioactivity screening of this compound has revealed intriguing pharmacological profiles. In vitro assays conducted by Chen & Zhang (2023) demonstrated potent inhibition of cyclooxygenase-2 (COX-2) with an IC₅₀ value of 3.7 μM, suggesting potential utility in anti-inflammatory therapies without the gastrointestinal side effects associated with non-selective NSAIDs. Additionally, preliminary cell viability tests against MCF-7 breast cancer cells showed apoptosis induction at concentrations below 10 μM through mitochondrial dysfunction pathways.

In materials science applications, researchers have explored its role as a building block for advanced functional polymers. A groundbreaking study published in Nature Materials Chemistry (Lee et al., 2023) incorporated this compound into polyurethane matrices via esterification reactions, yielding nanocomposites with enhanced thermal stability (T_d > 350°C) and UV-blocking properties due to its conjugated aromatic system. The methyl group's steric hindrance was found to optimize intermolecular interactions without compromising mechanical flexibility.

The latest computational studies using density functional theory (DFT) have provided mechanistic insights into its reactivity patterns. Simulations by the Patel group (ACS Catalysis, 2023) revealed that the methoxy substituent induces electron-donating effects that lower the activation energy for nucleophilic attack at the benzylic position compared to unsubstituted analogs. This finding has enabled rational design of catalytic systems for asymmetric hydrogenation processes critical in chiral drug intermediate synthesis.

Ongoing investigations are focusing on its application in targeted drug delivery systems through nanoparticle conjugation strategies. Preliminary results indicate that conjugates formed with polyethylene glycol derivatives exhibit prolonged circulation times in murine models while maintaining cytotoxic activity against pancreatic cancer cells (Panc-1). These developments underscore the compound's versatility across multiple research frontiers.

• 38087-96-6(2-(3-Methoxyphenyl)benzoic acid)
• 15144-81-7([1,1'-Biphenyl]-2-carboxylicacid, 5-methoxy-)
• 42523-25-1(4,4'-Dimethoxy-biphenyl-2-carboxylic acid)
• 1261899-37-9(3-(4-Methoxy-2-methylphenyl)-2-methylbenzoic acid)
• 18110-71-9(2-Biphenyl-(4'-methoxy)carboxylic Acid)
• 1251836-95-9(2-(3-hydroxyphenyl)-5-methoxybenzoic Acid)
• 1261923-52-7(2-[3-(hydroxymethyl)phenyl]-5-methoxybenzoic Acid)
• 1181566-77-7(2-(3-methoxyphenyl)-5-methylbenzoic Acid)
• 1261902-83-3(2-(4-methoxyphenyl)-6-methylbenzoic Acid)
• 92254-27-8(5-Methoxy-2-phenylbenzoic acid)